Lower Urinary Tract Symptom
7
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Urinary CTGF in Benign Prostatic Obstruction
Association Between Qmax/eGFR Ratio and LUTS Severity in Men Over 40
Uroflowmetry and IPSS Factors Influencing Surgical Decision
Clinical Outcomes and Ejaculatory Function in BPO Patients Treated With Silodosin
Safety and Efficacy Study for the Treatment of BPH (Enlarged Prostate)
Taiwan ACE Beads for Embolization Therapy in Symptomatic Benign Prostatic Hyperplasia
Moxibustion as an Adjuvant for Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms: a Pilot Study